Since our founding in 2003, Rondaxe has worked with many different type of companies:
- Emerging pharmaceutical and biotechnology companies
- Medium size pharmaceutical companies
- Large/established pharmaceutical companies
- Contract research, development and manufacturing organizations
- Venture and Private capital investors
Rondaxe is a member of the following industry organizations
Rondaxe has also formed partnerships with exciting companies in the area.
Rondaxe and TGen Drug Development (TD2) have formed a strategic alliance that will help emerging companies speed new high-quality treatments to cancer patients.
Rondaxe has partnered with Thomson Reuters Science to provide business solutions and analysis in the Generics and API Intelligence area.
Rondaxe has entered into an agreement with Oncoholdings to provide services for the development of promising preclinical and early clinical anti-cancer agents.
Rondaxe has formed a strategic alliance with Alvarez & Marsal’s Healthcare Industry Group to provide manufacturing, supply chain and compliance services to the pharmaceutical industry
What our Clients Say
Rondaxe provided invaluable CMC support and was instrumental in the successful out-licensing of our lead product, STA-4783.
AMPAC Fine Chemicals considers Rondaxe to be a ‘Key Skills Multiplier’ & have benefited from their support in critical strategic engineering and chemistry solutions. Additionally, their market knowledge & industry contact base prove to be of significant benefit to our business
Rondaxe provided comprehensive support to our CMC efforts on XL-119…and allowed our company to realize a substancial milestone payment.
Rondaxe Cost of Goods Software gives me a tool to quickly estimate manufacturing costs for intermediates and API, rigorously and reliably. The estimates are easy to understand and I can stand behind them when sharing with management or potential partners. Further, the output reports clearly highlight the key cost drivers and help my team focus their R&D efforts.